We are live on
!
Find out more
EI
EAM Investors Portfolio holdings
AUM
$866M
1-Year Est. Return
377.14%
This Fund
S&P 500
This Quarter
Est. Return
+47.43%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.17%
10 Year Est. Return
+19,957,666.26%
AUM
$540M
AUM Growth
+$30.8M
(+6%)
Cap. Flow
-$71M
Cap. Flow
% of AUM
-13.15%
Top 10 Holdings %
Top 10 Hldgs %
9.77%
Holding
405
New
161
Increased
21
Reduced
59
Closed
149
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Digital
APLD
|
+$4.62M |
| 2 |
WW
WW International
WW
|
+$3.97M |
| 3 |
Harmonic Inc
HLIT
|
+$3.58M |
| 4 |
SI-BONE Inc
SIBN
|
+$3.34M |
| 5 |
Tactile Systems Technology
TCMD
|
+$2.91M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Viking Therapeutics
VKTX
|
+$5.66M |
| 2 |
Harrow
HROW
|
+$5.57M |
| 3 |
Impinj
PI
|
+$5.06M |
| 4 |
Ceco Environmental
CECO
|
+$4.79M |
| 5 |
Par Pacific Holdings
PARR
|
+$4.38M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.89% |
| 2 | Technology | 25.18% |
| 3 | Industrials | 23.68% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Consumer Staples | 3.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Applied Digital
APLD
$7.77B
| $7.24M | 1.34% |
+774,423
| New | +$4.62M |
|
2
RxSight
RXST
$215M
| $6.38M | 1.18% |
221,415
+49,536
| +29% | +$1.1M |
|
3
Arlo Technologies
ARLO
$1.4B
| $5.92M | 1.1% |
543,039
+289,195
| +114% | +$2.35M |
|
4
UFP Technologies
UFPT
$1.84B
| $5.62M | 1.04% |
29,001
-22,328
| -43% | -$3.46M |
|
|
BELFB
5
Bel Fuse Inc Class B
BELFB
$3.88B
| $5.45M | 1.01% |
94,862
+43,953
| +86% | +$2.01M |
|
6
Weave Communications
WEAV
$491M
| $4.63M | 0.86% |
+416,392
| New | +$2.78M |
|
7
Applied Optoelectronics
AAOI
$8.04B
| $4.51M | 0.84% |
+757,304
| New | +$1.99M |
|
8
Limbach Holdings
LMB
$867M
| $4.38M | 0.81% |
177,303
-24,685
| -12% | -$497K |
|
9
Powell Industries
POWL
$8.46B
| $4.38M | 0.81% |
216,861
-42,615
| -16% | -$738K |
|
10
inTEST
INTT
$173M
| $4.24M | 0.78% |
161,339
-12,356
| -7% | -$272K |
|
|
ETNB
11
DELISTED
89bio
ETNB
| $4.1M | 0.76% |
216,438
-69,982
| -24% | -$1.23M |
|
|
PENG
12
Penguin Solutions Inc
PENG
$2.76B
| $4.09M | 0.76% |
+140,973
| New | +$2.83M |
|
|
CBAY
13
DELISTED
Cymabay Therapeutics
CBAY
| $4.08M | 0.76% |
372,624
+56,030
| +18% | +$522K |
|
14
Beazer Homes USA
BZH
$907M
| $3.96M | 0.73% |
+140,076
| New | +$2.86M |
|
15
Aehr Test Systems
AEHR
$2.48B
| $3.8M | 0.7% |
92,162
-23
| -0% | -$755 |
|
16
Remitly
RELY
$4.74B
| $3.78M | 0.7% |
200,816
| – | – |
|
|
WW
17
DELISTED
WW International
WW
| $3.76M | 0.7% |
+560,035
| New | +$3.97M |
|
18
Axcelis
ACLS
$4.12B
| $3.76M | 0.7% |
20,485
-8,705
| -30% | -$1.25M |
|
19
Extreme Networks
EXTR
$3.86B
| $3.7M | 0.69% |
+142,027
| New | +$2.8M |
|
|
20
SI-BONE Inc
SIBN
$737M
| $3.7M | 0.68% |
+136,957
| New | +$3.34M |
|
|
IMGN
21
DELISTED
Immunogen Inc
IMGN
| $3.63M | 0.67% |
+192,519
| New | +$2.27M |
|
22
MiMedx Group
MDXG
$626M
| $3.63M | 0.67% |
+549,333
| New | +$2.8M |
|
23
Red Robin
RRGB
$134M
| $3.61M | 0.67% |
260,833
-80,538
| -24% | -$1.08M |
|
24
Preformed Line Products
PLPC
$1.52B
| $3.6M | 0.67% |
23,092
+1,233
| +6% | +$179K |
|
|
25
Harmonic Inc
HLIT
$1.21B
| $3.6M | 0.67% |
+222,718
| New | +$3.58M |
|
Similar funds
NEPWA
RWM
MCM
HP
OMG
RB
BGC
ICCFIA
EAM Investors's Q2 2023 Portfolio in Review
As of Q2 2023, EAM Investors held 405 positions worth $540M, up 6% from $509M the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
EAM Investors withdrew a net $71M in Q2 2023, closing 149 positions and reducing 59 holdings. Its most notable exit was Viking Therapeutics, an estimated $5.66M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Technology and Industrials.
Against the trend, EAM Investors opened a new position in Applied Digital worth $7.24M.
- EAM Investors's largest Q2 2023 buy was Applied Digital: 774,423 shares worth $7.24M.
- EAM Investors added most to Arlo Technologies in Q2 2023, an estimated $2.35M increase.
- EAM Investors's biggest Q2 2023 reduction was Harrow, cutting an estimated $5.57M.
- EAM Investors fully exited Viking Therapeutics in Q2 2023, selling an estimated $5.66M.
- EAM Investors's ten largest holdings make up 9.8% of its $540M portfolio in Q2 2023.
- EAM Investors opened 161 new positions and closed 149 in Q2 2023.
- EAM Investors's portfolio value rose 6% quarter-over-quarter to $540M.
Based on EAM Investors's 13F filing for Q2 2023, filed 11 Aug 2023.